,
Staar Results 2024 Expectations

Staar Results 2024 Expectations

Evo icl™ continues to outpace refractive industry growth. On that date, parents and families can view their child’s individual.


Staar Results 2024 Expectations

Staar surgical (nasdaq:staa) first quarter 2024 results key financial results. Thu, apr 4, 2024, 7:00 am 5 min.

Staar Surgical Announces Preliminary Net Sales For First Quarter 2024.

View the latest staa earnings date, analysts forecasts, earnings history, and conference call transcripts.

Staar Surgical Company (Nasdaq:k), A Leading Developer, Manufacturer And Marketer Of The Evo Family Of Implantable Collamer® Lenses (Evo Icl™) For Myopia,.

On that date, parents and families can view their child’s individual.

Images References :

Staar Surgical Reports Fourth Quarter And Fiscal Year 2023 Results.

Staar surgical (nasdaq:staa) first quarter 2024 results key financial results.

Staar Surgical Reports First Quarter 2024 Results.

View the latest staa earnings date, analysts forecasts, earnings history, and conference call transcripts.

More Details